Please keep your hands and feet inside the vehicle until it comes to a complete stop...this morning we saw NYSE net ticks surge past +1000...less than an hour ago we saw this swing 180 degrees and push past -1000....now we have the round trip as buyers rush in and pop the market from its lows as net ticks hit +1000 again.
Discuss this article:
Post your own comment
More articles:
Bristol-Myers Squibb (BMY) read more...
Option traders are betting on a continued slump for casino concern Bally Technologies Inc. (BYI: sentiment, chart, options) , despite an upbeat analyst endorsement over the weekend. read more...
Aetna Inc. (AET) read more...
Research In Motion Limited (RIMM: sentiment, chart, options) has attracted an unusual amount of attention from option traders today – especially on the put side of the tape. In early afternoon activity, the BlackBerry maker has seen roughly 17,000 puts change hands, already surpassing the stock's expected single-session volume of about 15,000 puts. read more...
Earnings season is upon us, and investors all across Wall Street are hoping to take advantage of these potentially volatile few weeks. Large bull (and bear) gaps, upgrades and downgrades, and short squeezes all become increasingly more likely during this period, as companies meet, beat, or miss quarterly expectations. As such, it is imperative that traders be well equipped to deal with all of the eventualities. read more...
NRG Energy (NRG) read more...
Bullish call spreads are known by a variety of different names among options traders. But whether the position is a bull call spread, bullish debit spread, or a long vertical call spread, it is still constructed by purchasing an at-the-money or in-the-money call while simultaneously selling an out-of-the-money call. The reasoning behind pairing up these seemingly contradictory options is really quite simple: limited risk. read more...
McDonald's Corp. (MCD) read more...
Amylin Pharmaceuticals Inc. (AMLN: sentiment, chart, options) makes and markets two injectable diabetes drugs, Byetta and Symlin, that are approved as adjunct diabetes therapies, according to Hoover's. The company is working on other diabetes drugs, including a once-weekly version of Byetta, as well as treatments for obesity. read more...
Have you ever found yourself chasing profits to make up for prior losing trades? Or quickly exiting a trade to avoid losses, only to watch the position come back strong after your untimely exit? If so, then adding stop losses to your trading tool box should be a top priority. These handy trading tools are basically orders placed with a broker to buy or sell a position once the equity or option reaches a certain price. But before we dive head-first into the various methods of implementing a stop loss, we should first understand the reasons why someone would, or better yet should, implement a trading strategy before jumping into the market. read more...
Today's Most Popular Stories
working... 
